Search results for " biotherapeutic"

Webcast Peptalk 2024 – San Diego
PepTalk provides a comprehensive program and innovative solutions for optimizing biotherapeutics. Conference tracks cover a range of topics including antibody engineering, bispecific antibody develo…

Article Determining and Optimizing Dynamic Binding Capacity
Dynamic binding capacity (DBC) indicates the quantity of a specific biomolecule that can be bound during a chromatography purification step under a specific set of process conditions. Determ…

Article eBook: Purification of Antibody Therapeutics - Approach for Diversified Pipeline
Antibody therapeutics are the largest class of biotherapeutics. Over the years, development beyond traditional monoclonal antibodies (mAbs) has increased. Today, we see multispecific and bispe…

Article Expanding the Emerging Therapeutic Horizon
Despite the successes that have already been achieved with emerging therapy development and manufacturing, companies are still facing numerous challenges. Aspects such as demand for accelerate…

Tip Considerations for smarter and faster process development
Biopharmaceutical Process Development - Considerations for Smarter and Faster Process Development. What you will learn: Industry drivers to go smarter and faster in process development S…

Webcast PepTalk
PepTalk connects protein science researchers from around the globe to share case studies, unpublished data, breakthroughs, and solutions that support and enhance biotherapeutics R&D.

Article Report from the 12th Plasma Product Biotechnology Forum
When questioned on what other areas relevant to plasma biotherapeutics they would like to see, some responses given were: · Sustainability · Artificial Intelligence (AI)…

Article PEPTalk Event
  Visit us at the PepTalk conference in San Diego. Attend our talk, powerpoint presentations, and panel discussions to learn the latest in protein science. LEARN MORE >> …

Webcast e-learning: Principles of Cell Line Development
This free online course provides an overview of how cell line development plays a critical role in a biotherapeutic drug’s path to market.

Article Capture of Bispecific Antibodies and Removal of Product-Related Impurities
The biotherapeutics pipeline is becoming increasingly diverse as antibody variants such as bispecifics, conjugates, and fragments move through preclinical stages to commercial manufacturin…

Previous PageNext Page